Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5958_Библиотеки_им_академика_М_И_Перельмана
.pdf
Alpinia galanga (L.), 78, 251, 253,
261, 266
antiulcer property, 267
English names, 253
geographical distribution,
253–258
immunomodulatory
property, 267
synonyms, 253
taxonomy, 253
toxicity profile of, 268
traditional medicinal uses of,
258–260
vernacular names, 253
Alpinia officinarum, 251, 268, 271
common/English names, 268
family, 268
geographical distribution, 269
synonyms, 268
taxonomy, 269
toxicity profile of, 274
traditional medicinal uses
of, 269
vernacular names, 269
alternative medicine, 392
Alzheimer’s disease (AD), 10, 409
Amalaki, 201
amla (Emblica officinalis), 26, 31
gooseberry, 221–222
in Ayurveda classical text,
225–231
amlaki, 180, 382
AMP-activated protein kinase
(AMPK), 29
AMPK. See AMP-activated protein
kinase (AMPK )
Amrutikarna,3
Amylcure DS capsule, 115
amyloid beta-peptide (Ab ), 95, 267
amyloid precursor protein (APP), 240
anaemia, 31
Anagnisadhya vati,9
Ankaferd blood stopper (ABS), 271
antiarthritic activity, 31, 135
antiasthmatic activity, 152
antidiabetic, 28–31
API. See Ayurvedic Pharmacopoeia of
India (API)
APP. See amyloid precursor protein
(APP)
Arista, 2–3, 12
arteminisine, 392
Artemisia annua, 392
AS. See Astanga Sangraha (AS)
Asava, 2–3, 12
Asavaristra,2
ascorbic acid, 292
ASD. See autism spectrum disorder
(ASD)
A
¨
shtanga Ayurveda, 329
Ashwagandha, 89, 104
Ashwagandha Rasayana, 101
Ashwagandhanolide, 100
Asparagus racemosa, 377, 379
aspartate aminotransferase (AST),
60
Astanga Hridya (AH), 26
Astanga Sangraha (AS), 26, 225
asthma bronchitis, 55–56
Astragalus membranaceus, 125
Aswagandharishtam, 53
Atharva Veda, 176, 326
ATP. See adenosine triphosphate
(ATP)
ATP-binding cassette transporters 5
and 8 (ABCG5/8), 59
attention deficit hyperactivity
disorder (ADHD), 179, 409
Australia, traditional aboriginal
medicine from, 406
Australian aboriginal traditional
medicine, 413
autism spectrum disorder (ASD),
181
Avala,16
Avaleha,10
Avleha,2
Ayurgenomics, 330
Ayurveda, 1–2, 6, 14, 18, 22–23, 46,
73, 89, 109, 250–25 1, 289–290,
326, 374
advantages, 362–363
422 Subject Index
https://t.me/med1917
amla in Ayurveda classical text,
225–231
anti-Parkinson effects, 95–96
antiaging, 101
antidiabetic effect, 101
antivenom, 99
Ayurveda-based approach in
drug discovery, 362
and Bacopa monnieri, 176–178
basic principles of, 328–329
breast cancer, 96
cervical cancer, 96
clinical evidence for, 406–411
clinical trials, 104
composition, 92–93
concerns, 363
ethnomedicinal practice,
101–103
formulations, 225
immunity, 100–101
market potential and marketed
formulations, 104–105
neuroprotective effects, 93–95
ovarian cancer, 96–97
Rasna in, 251–252
RCT and compatibility with,
375–376
role of W. somnifera in anxiety,
97–99
studied herbs in, 379–382
taxonomical classification, 91–92
therapeutical potential, 93
Ayurveda, Yoga, Unani, Siddha and
Homeopathy (AYUSH), 46
Ayurvedic drugs, 193–194, 326
basic principles of Ayurveda,
328–329
discovery, 328, 362
essential considerations in,
333–334
integrating Ayurvedic
principles into modern DD,
329–331
reverse pharmacology, 331–333
suggested sequential steps in,
331
Ayurvedic formulations, 1–2, 290,
377
anticancer, 81
antidiarrhoeal, 83
antihyperlipidemic and anti-
diabetic activity, 80–81
antithrombotic, 82–83
antiulcer, 81–82
Arista and Asava, 2–3
Avaleha,10
Ayurvedic medicinal pla nts in
preclinical and clinical
trials, 376–382
Ayurvedic properties of
Shallaki, 75
B. monnieri-based Ayurvedic
formulations, 178–181
Boswellia in Ayurvedic texts,
74–75
churna,10
containing Tulsi, 114–115
Ghrita,10
Guggulu,11
hepatoprotective activity, 84
immune re sponse, 82
modern medicinal uses, 76
modern science perspectives,
11–18
neuroprotective effects, 84–85
prepared from black pepper,
152–156
Rasa Rasayana, 3–9
RCT and compatibility with
Ayurveda, 375–376
Sandhigata vata/Arthritis,
76–80
science behind action of, 75–76
skin disorders, 83
standardization of Brahmi-
based and, 188–194
Taila,11
taxonomy and
phytochemistry, 76
varg of Shallaki in different
literature sources, 75
Vati or Gutika, 9–10
Subject Index 423
https://t.me/med1917
Ayurvedic herbal formulations with
ginger for different health issues,
54–56
Ayurvedic importance and ethno-
pharmacological relevance,
149–150
balancing doshas with black
pepper, 150
Ayurvedic medicinal plants, 334–362
Ayurvedic medicinal plants in
preclinical and clinical trials, 376
polyherbal formulations,
376–379
studied herbs in Ayurveda,
379–382
Ayurvedic medicines, 2, 326, 334
systems, 193
Ayurvedic perspective on Triphala,
202–203
Ayurvedic pharmacopeia, 2
Ayurvedic Pharmacopoeia of India
(API), 252
Ayurvedic Rasashastra, 216
Ayurvedic significance and ethno-
pharmacological relevance,
110–111
AYUSH. See Ayurveda, Yoga, Unani,
Siddha and Homeopathy (AYUSH)
Azadirachta indica. See Nimba
(Azadirachta indica)
B cell lymphoma (BCL-2), 96
Bacopa monnieri, 176–177, 379
Ayurveda and, 176–178
B. monnieri-based Ayurvedic
formulations, 178–181
Bacopa
monnieri þAyurveda, 177
phytochemistry of, 181–188
standardization of Brahmi-
based and Ayurvedic formu-
lations, 188–194
bacoside A, 181
Badi Elaichi (Elettaria cardamomum),
152–154
Balanites aegyptiaca,9
Bambusa arundinacea. See
Vamshalochana (Bambusa
arundinacea)
Ban tulsi (Ocimum basilicum), 108
Basti, 329
BCL-2. See B cell lymphoma
(BCL-2)
benign prostatic hyperplasia
(BPH), 412
beta-cyclodextrin (b-CD), 35
b-bisabolene, 48
b-boswellic acid (b-BA), 76
b-sesquiphellandrene, 48
b-TCP, 312
Betula utilis,9
Bhaisajyaratnavali (BR), 26
Bhasma, 2–3
method of preparation of, 3–5
Bhavaprakasa (BP), 26
Bhenda (Terminalia belerica),
152–154
BHT. See butylated hydroxytoluene
(BHT)
Bibhitak, 31, 114, 201
Bibhitaki (Terminalia bellerica), 31
bioactive components, 159
biotite mica, 3
black pepper (Piper nigrum), 35, 49,
79, 148–151
balancing doshas with, 150
clinical stu dies on, 167–169
conditions, 169–172
different ancient Ayurvedic
formulations prepared from,
152–156
different modern formulations
available containing,
156–158
modern techniques used in
extraction of, 162–167
piperine effect on digestive
tract, 169
vitiligo, 169
blood urea nitrogen (BUN), 267
BMI. See body mass index (BMI)
body mass index (BMI), 215, 308, 330
424 Subject Index
https://t.me/med1917
bone-related clinical studies, CQ in,
299–300
bonesetter, 290
Boswellia,74
in Ayurvedic texts, 74–75
B. carterii ,74
B. dalzielii,84
B. frereana,74
B. neglecta,74
B. ovalifoliolata, 81, 84
B. papyrifera,74
B. rivae,74
B. sacra,74
B. serrata, 74, 78–79, 305, 310,
377, 381
boswellic acid, 80–81
botanical drug development, 363
challenges and recom-
mendations, 367–369
pharmaceutical industry,
363–367
BP. See Bhavaprakasa (BP)
BPH. See benign prostatic hyper-
plasia (BPH)
BR. See Bhaisajyaratnavali (BR)
Brahmi ghrita, 179
Brahmi rasayana, 179–180
Brahmi-based and Ayurvedic formu-
lations, standardizationof, 188–194
Brahmi þAyurveda, 177
brain health disorders, 240
brass, 8
breast cancer, 96
cell, 310
Bresol tablet, 117
bronze Bhasma,9
BUN. See blood urea nitrogen (BUN)
Butea frondosa,9
1-butyl-3-methylimidazolium hexa-
fluorophosphate
({BMIM}{PF6}), 123
butylated hydroxytoluene (BHT), 265
C-reactive protein (CRP), 308
CA2. See Cornu Ammonis 2 (CA2)
CA3. See Cornu Ammonis 3 (CA3)
calcium, 291–292
Calotropis gigantea, 305
cAMP. See cyclic adenosine mono-
phosphate (cAMP)
Camptotheca acuminata, 392
camptothecin, 392
cancer cell, 206
cancer-related mortality and
morbidity, 62
Candida albicans, 305
cannabidiol (CBD), 367
caplets, 16
Caraka Samhita (CS), 26
carbohydrate, 292
cardiovascular disease, 214
cardiovascular health and
Triphala, 214
CAT. See catalase (CA T)
catalase (CAT), 304
catechin, 101
Catharanthus roseus, 392
CBD. See cannabidiol (CBD)
CC.Seecolumn chromatography (CC)
CCRAS. See central council for
research in Ayurvedic sciences
(CCRAS)
CD. See Charakadatta (CD)
CDK2. See cyclin dependent protein
kinase-2 (CDK2)
central council for research in
Ayurvedic sciences (CCRAS), 411
central nervous system (CNS), 409
effect on, 133–134
Cephalotaxus harringtonii, 392
cerebral glutamic acid, 179
cervical cancer, 96, 408
Ceylon (Plumbago zeylanica), 152
CFA. See Complete Freunds Adjuvant
(CFA)
Chakrapani,5
Charaka, 5, 251
Charakadatta (CD), 26
Chavak (Piper retrofractum), 152
chloramphenicol (C), 130
cholesterol-7a-hydroxylase
(CYP7A1), 59
Subject Index 425
https://t.me/med1917
cholesteryl ester hydrolase, 304
chronic diseases, management of, 63
chronic ethanol exposure, 60
chronic fever, 55
churnas,3,10
Chyawanprash, 245, 377
Cinchona officinalis, 362, 392
Cissus quadrangularis (CQ), 289, 305,
310
analgesic, anti-inflammatory,
and antihemorrhoidal
activity, 306–307
antiarthritic activity, 304–305
anticancer activity, 310
antidiabetic activity, 304
antimicrobial activity, 301
antioxidants and related
activity, 301–304
antiulcer activity, 306
biomedical applications of,
311–313
in bone-related clinical studies,
299–300
clinical studies for an anti-
arthritic effect, 305–306
clinical studies for weight loss
and obesity, 307–309
hepatoprotective activity,
300–301
intellectual property rights
related to, 314
metabolic syndromes, 307
in nanotechnology, 310–311
neurological activity, 309–310
osteoporotic and osteoblast-
related activity/bone-related
activity, 297–299
phytochemical analysis,
291–297
preclinical and clinical
pharmacology of, 297
role in sarcopenia, 310
safety assessment in animal
models and in clinical stud-
ies, 313–314
wound healing activity, 309
Cittaratta, 251
clinical evidence for Ayurveda,
406–411
clinical studies, 406
CMT. See congenital muscular torti-
collis (CMT)
CNS. See central nervous system
(CNS)
cobra (Naja naja), 99
colchicines (Colchicum
autumnale), 363
Colchicum autumnale. See colchi-
cines (Colchicum autumnale)
colitis, protective effect on
ulcerative, 62
Collyrium, 4
column chromatography (CC), 92
combination therapy, 169
Commiphora mukul,11
Commiphora wightii,78
compatibility with Ayurveda,
375–376
Complete Freunds Adjuvant
(CFA), 305
congenital muscular torticollis
(CMT), 412
copper, 7
copper-based formulas, 12
copper oxide nanoparticles
(CuONPs), 311
Cornu Ammonis 2 (CA2), 93
Cornu Ammonis 3 (CA3), 93
cough syrup, 115–116
Tulasi, 117–118
Council of Scientific and Industrial
Research (CSIR), 333
COX-1. See cyclooxygenase-1 (COX-1)
COX-2. See cyclooxygenase-2 (COX-2)
Cp. See cysteine protease (Cp)
CQ. See Cissus quadrangularis (CQ)
CREB. See cyclic adenosine
monophosphate response
element-binding protein (CREB)
CRP. See C-reactive protein (CRP)
Crux cough syrup, 118
CS
. See Caraka Samhita (CS)
426 Subject Index
https://t.me/med1917
CSIR. See Council of Scientific and
Industrial Research (CSIR)
Curcuma longa L. See turmeric
(Curcuma longa L.)
curcumin, 30
curcumin 3, 156
low bioavailability, 35
curcuminoids, 35, 170
cyclic adenosine monophosphate
(cAMP), 299
cyclic adenosine monophosphate
response element-binding protein
(CREB), 64
cyclin dependent protein kinase-2
(CDK2), 270
cyclooxygenase-1 (COX-1), 307
cyclooxygenase-2 (COX-2), 31, 307
cyclosporine, 61
CYP7A1.Seecholesterol-7a-
hydroxylase (CYP7A1)
Cyperus rotundus. See Musta (Cyperus
rotundus)
cysteine protease (Cp), 292
Daboia russelii. See viper (Daboia
russelii)
Dabur Tuls i drops, 118
data-mining classical texts for in-
sights, 24–28
DD. See drug discovery (DD)
Decofcyn cough syrup, 115
dehydroepiandrosterone sulfate
(DHEA-S), 104
deoxyribonucleic acid (DNA), 61
Department of Science and
Technology (DST), 178
Devil’s claw (Harpagophytum
procumbens), 413
DEXA. See dual-energy X-ray absorp-
tiometry (DEXA)
DHA.Seedocosahexaenoic acid (DHA)
Dhatri loha, 231
DHEA-S. See dehydroepiandroster-
one sulfate (DHEA-S)
diabetes mel litus (DM), 408
diarrhea, 55
diarylheptanoids, 34, 272
dichloromethane (CQD), 298
digestive tract, piperine effect
on, 169
Digitalis purpurea, 362
dipeptidyl peptidase-4 (DPP-4), 101
2,2-diphenyl-1-picryl-hydrazylhydrate
(DPPH), 236, 304
diseases, Triphala effects on,
205–216
Divya Churna, 49
Divya Pidantaka Kvatha, 49
Divya Pidantaka Taila, 49–53
Divya Svasari Rasa, 53
DM. See diabetes mellitus (DM)
DNA. See deoxyribonucleic acid
(DNA)
docetaxel (DTL), 130
docosahexaenoic acid (DHA), 16
doshas, 73, 150, 202
Dox. See doxorubicin (Dox)
doxorubicin (Dox), 96, 262
DPP-4. See dipeptidyl peptidase-4
(DPP-4)
DPPH. See 2,2-diphenyl-1-picryl-
hydrazylhydrate (DPPH)
Draksha (Vitis vinifera), 229, 271
drug discovery (DD), 325–326
Ayurveda-based approach in,
362–363
Ayurvedic drug discovery,
328–334
botanical drug development,
363–369
challenges in modern DD
approach, 328
development of new drugs,
334–362
lead compound optimization,
327–328
lead compound screening, 327
modern drug development
process, 326
target iden tification, 327
drugs, 3, 11. See also botanical drug
development
Subject Index 427
https://t.me/med1917
DST. See Department of Science and
Technology (DST)
dual-energy X-ray absorptiometry
(DEXA), 308
dulal tulsi (Ocimum canum), 108
dysentery, 55
EAC. See Ehrlich ascites carcinoma
(EAC)
EAE. See enzyme-assisted extraction
(EAE)
ECs. See endothelial cells (ECs)
EGFR. See epidermal growth factor
receptor (EGFR)
Ehrlich ascites carcinoma (EAC),
263, 277
EHTN. See essential hypertension
(EHTN)
electronic medical record (EMR), 368
Elettaria cardamomum. See Badi
Elaichi (Elettaria cardamomum)
ELISA. See enzyme linke d im-
munosorbent assay (ELISA)
Embelia ribes. See Vidanga (Embelia
ribes)
Emblica officinalis, 9, 79, 221, 376,
382
amla in Ayurveda classical text,
225–231
analgesic, antipyretic, and
antimicrobial activities,
235–236
antioxidant activity, 236–237
antiproliferative, antitumour,
and antimutagenic
activities, 239–240
antitussive and respiratory
problems, 244
cardioprotective activity, 243
gastroprotective activity,
241–242
general description of, 222
hepatoprotective activity, 241
immunomodulatory and anti-
inflammatory activities,
237–239
lipid profile modulation,
243–244
neuroprotective and antiaging
activity, 240
pharmacological activity
of, 235
phytochemistry of, 231–234
scientific classification and
morphological description,
222–223
serum glycaemic modulation,
242–243
vernacular names, 223–225
Emblica officinalis. See amla (Emblica
officinalis); Indian gooseberry
(Emblica officinalis)
EMR. See electronic medical record
(EMR)
endothelial cells (ECs), 59
enzyme linked immunosorbent
assay (ELISA), 65
enzyme-assisted extraction (EAE),
124–125
EOs. See essential oils (EOs)
epidermal growth factor receptor
(EGFR), 207
ER. See estrogen receptor (ER)
ER-b. See estrogen receptor-b
(ER-b)
ERK. See extracellular-signal-
regulated kinase (ERK)
erythrocyte sedimentation rate
(ESR), 411
Escherichia coli, 272
ESR. See erythrocyte sedimentation
rate (ESR)
essential hypertension (EHTN), 180
essential oils (EOs), 127, 161
estrogen, 96
estrogen receptor (ER), 96
estrogen receptor-b (ER-b), 299
Eucommia ulmoides, 125
Eugenia aromatica (Syzygium
aromaticum), 152–154
eugenol (1-hydroxy-2-methoxy-4-
allylbenzene), 130
428 Subject Index
https://t.me/med1917
evidence-based formulations in nu-
traceuticals and functional foods,
57–59
extracellular-signal-regulated kinase
(ERK), 64, 207
extraction, 11
EAE, 124–125
ionic-liquid extraction method,
123–124
microwave-assisted extraction,
121–122
modern techniques of, 118
PEF extraction, 126
PLE, 125–126
SC-CO
2
, 122–123
UAE, 118–121
FAS. See fatty acid synthase (FAS)
FAs. See fatty acids (FAs)
FAT/CD36. See fatty acid translocase/
cluster of differentiation 36 (FAT/
CD36)
fatty acid synthase (FAS), 272
fatty acid translocase/cluster of dif-
ferentiation 36 (FAT/CD36), 60
fatty acids (FAs), 16, 112
FDA. See Food and Drug Adminis-
tration (FDA)
Ferula asafoetida L., 49
Feverex syrup, 115
FFA. See free fatty acids (FFA)
filfil siyah, 154
flavonoids, 112, 232, 292–293, 301
focused screening, 327
Food and Drug Administration
(FDA), 2
free fatty acids (FFA), 172
fruits, 159–161
functional foods, evidence-based
formulations in, 57–59
GABA. See gamma-aminobutyric
acid (GABA)
GAE. See gallic acid equivalent (GAE)
Galangal, 250
Alpinia calcarata, 274–276
Alpinia galanga (L.), 253–260
Alpinia officinarum, 268–269
anti-HIV property, 267
anti-inflammatory activity,
265–266, 273–274
antiacetylcholinesterase
activity, 270
antidiabetic activity, 266–267
antifungal activity, 264
antihaemorrhagic activity, 271
antimicrobial activity, 263–264,
271–272
antioxidant activity,
264–265, 270
antiplatelet activity, 270
antiviral activity, 272
antivitiligo activity, 274
cytotoxic and apoptotic effects,
261–263
cytotoxic/antitumour
activity, 270
hepatoprotective activity, 267
hypolipidaemic activity in vitro
studies, 272–273
hypolipidaemic activity in vivo
studies, 273
melanogenesis inhibitory
activity, 273
neuroprotective activity, 267
pharmacological actions, 260
pharmacological activity of
Alpinia calcarata, 276–279
pharmacological
properties, 270
phytochemicals present in
galangal species, 252–253
phytochemistry, 252
Rasna in Ayurveda, 251–252
spermatogenesis activity,
260–261
toxicity profile of Alpinia
galanga (L.), 268
toxicity profile of Alpinia
officinarum, 274
treatment of erectile
dysfunction, 274
Subject Index 429
https://t.me/med1917
galangin, 271, 274
Galega officinalis. See metformin
(Galega officinalis)
gallic acid equivalent (GAE), 304
gamma-aminobutyric acid (GABA),
97–98, 179, 240, 309
gamma-aminobutyric acid type
(GABA
A
), 98
Gandhaka,3
Gandhakaare,3
Gandhanakuli, 251
GAP-43. See growth-associated
protein-43 (GAP-43)
gas chromatography-mass
spectrometry (GC–MS), 92
gastrointestinal health, 61–62
gastrointestinal tract (GIT), 74
GC–MS. See gas chromatography-
mass spectrometry (GC–MS)
GFAP. See glial fibrillary acidic
protein (GFAP)
Ghanavati,9
ghee, 10–11
Ghrita, 10–11, 16–17
ginger (Zingiber officinale), 47, 49, 79,
150, 152, 269, 333, 377, 381
anti-inflammatory effect,
59–60
anticancer effect, 62–63
antidiabetic effect, 63–64
antiobesity effect, 65–66
Ayurvedic herbal formulations
with ginger for different
health issues, 54–56
biological activities of ginger in
different uses, 59
chemical constituents of, 48
classical Ayurvedic form u-
lations with ginger, 49–54
effect on oxidative stress and
hypertension, 65
evidence-based formulations
in nutraceuticals and func-
tional foods, 57–59
gastrointestinal health, 61–62
ginger and components, 47
management of chronic
diseases, 63
management of nausea and
vomiting, 63
neuroprotective and memory-
enhancing effect, 64
pain relief effect, 62
protective effect on kidney
health, 61
protective effect on liver health,
60–61
protective effect on respiratory
disorders, 64–65
protective effect on ulcerative
colitis, 62
rhizomes, 58
Siddha, 46–47
gingerols, 48
GIT. See gastrointestinal tract (GIT)
gk. See glucokinase (gk)
glial fibrillary acidic protein (GFAP),
95–96
GLP-1. See glucagon-like peptide-1
(GLP-1)
glucagon-like peptide-1 (GLP-1),
172
glucokinase (gk), 136
glutathione peroxidase (GPx), 301
glutathione reductase (GSR), 237
glutathione S-transferase (GST), 306
glycowithanolides, 93
Glycyrrhiza glabra, 49, 78, 271
gold, 7
gold nanoparticles (AuNPs), 311
GPx. See glutathione peroxidase
(GPx)
Grafa Churena,2
greater galangal, 251
growth-associated protein-43 (GAP-43),
93
GSR. See glutathione reductase
(GSR)
GST. See glutathione S-transferase
(GST)
Guduchi (Tinospora cordifolia
),
78–79, 229
430 Subject Index
https://t.me/med1917
Guduchyadi ghrita medhya
rasayana, 377
Guggulu, 11, 17
Guggulu-lipid, 17
Guggulu-sterol, 17
Gutika, 9–10
Gymnema sylvestre,9,57
HAM-D. See Hamilton-D (HAM-D)
Hamilton-D (HAM-D), 377
Haridra (Curc uma longa). See
turmeric (Curcuma longa L.)
Haritaki (Terminalia chebula),
180, 228
Haritaki, 201
Harpagophytum procumbens. See
Devil’s claw (Harpagophytum
procumbens)
HbA1c. See hemoglobin A1c (HbA1c)
HDL. See high density lipoprotein
(HDL); high-density lipoprotein
(HDL)
HDL-C. See high-density lipoprotein-
cholesterol (HDL-C)
healthcare systems, 391
heat reflux extraction (HRE), 167
HEE. See hot ethanol extract (HEE)
heme oxygen ase-1 (HO-1), 61, 307
hemoglobin A1c (HbA1c), 64, 80
Henry’s law, 36
hepatocyte nuclear factor 4 alpha
(HNF4A), 60
hepatoma G2 (HepG2), 61
HepG2. See hepatoma G2 (HepG2)
herbal formulas under Rasa
Rasayana, 5
herbal medications, 100
herbs in Ayurveda, 379–382
hexane (CQH), 298
hexokinase (hk), 136
high density lipoprotein (HDL), 308
high throughput screening (HTS),
327, 330
high-density lipoprotein (HDL), 408
high-density lipoprotein-cholesterol
(HDL-C), 66
high-performance liquid chroma-
tography (HPLC), 92, 330
Himalaya Abana, 53
Himalaya Mentat, 53
Hippobosca maculate, 311
HIV. See human immunodeficiency
virus (HIV)
hk. See hexokinase (hk)
HL-60 cell lines, 59, 263
HMG-CoA-R. See 3-hydroxy-3-
methylglutaryl-CoA reductase
(HMG-CoA-R)
hMSCs. See human mesenchymal
stem cells (hMSCs)
HNF4A. See hepatocyte nuclear
factor 4 alpha (HNF4A)
HO-1. See heme oxygenase-1 (HO-1)
homoharringtonine, 392
Hordeum vulgare,9
hot ethanol extract (HEE), 276
hot water extract (HWE), 276
HPLC. See high-performance liquid
chromatography (HPLC)
HPV. See human papillomavirus
(HPV)
HRE
. See heat reflux extraction
(HRE)
hTERT. See human te lomerase
reverse transcriptase (hTERT)
HTS. See high throughput screening
(HTS)
human immunodeficiency virus
(HIV), 413
human mesenchymal stem cells
(hMSCs), 312
human papillomavirus (HPV), 96
human telomerase reverse
transcriptase (hTERT), 58
human white adipocytes (hWA),
309
hWA. See human white adipocytes
(hWA)
HWE. See hot water extract (HWE)
hydrogen peroxide (H
2
O
2
), 301
hydrolysis, 121
hydrotropes, 162
Subject Index 431
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана